ATE274523T1 - Tetrapeptid, das prostatafunktionen reguliert sowie seine zusammensetzungen und verwendungen - Google Patents

Tetrapeptid, das prostatafunktionen reguliert sowie seine zusammensetzungen und verwendungen

Info

Publication number
ATE274523T1
ATE274523T1 AT01273785T AT01273785T ATE274523T1 AT E274523 T1 ATE274523 T1 AT E274523T1 AT 01273785 T AT01273785 T AT 01273785T AT 01273785 T AT01273785 T AT 01273785T AT E274523 T1 ATE274523 T1 AT E274523T1
Authority
AT
Austria
Prior art keywords
tetrapeptide
regulation
functions
prostate functions
compositions
Prior art date
Application number
AT01273785T
Other languages
English (en)
Inventor
Vladimir Khatskelevi Khavinson
Vladimir Viktorovich Malinin
Evgeny Iosifovich Grigoriev
Original Assignee
Sankt Peterburgskaya Obschestv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankt Peterburgskaya Obschestv filed Critical Sankt Peterburgskaya Obschestv
Application granted granted Critical
Publication of ATE274523T1 publication Critical patent/ATE274523T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01273785T 2001-01-25 2001-10-16 Tetrapeptid, das prostatafunktionen reguliert sowie seine zusammensetzungen und verwendungen ATE274523T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2001102099/14A RU2177802C1 (ru) 2001-01-25 2001-01-25 Тетрапептид, регулирующий функции предстательной железы, фармакологическое средство на его основе и способ его применения
PCT/RU2001/000433 WO2002066497A2 (en) 2001-01-25 2001-10-16 Tetrapeptide regulating prostate functions and its compositions and methods

Publications (1)

Publication Number Publication Date
ATE274523T1 true ATE274523T1 (de) 2004-09-15

Family

ID=20245158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01273785T ATE274523T1 (de) 2001-01-25 2001-10-16 Tetrapeptid, das prostatafunktionen reguliert sowie seine zusammensetzungen und verwendungen

Country Status (6)

Country Link
EP (1) EP1353939B1 (de)
AT (1) ATE274523T1 (de)
AU (1) AU2002221216A1 (de)
DE (1) DE60105204T2 (de)
RU (1) RU2177802C1 (de)
WO (1) WO2002066497A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
RU2283646C2 (ru) * 2004-04-27 2006-09-20 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Раствор простакор для инъекций
EA020866B1 (ru) 2013-02-28 2015-02-27 Замертон Холдингс Лимитед Пептиды с цитопротекторной активностью и фармацевтическая композиция
RU2640931C1 (ru) * 2017-03-23 2018-01-12 Закрытое акционерное общество "ФАРМ-ХОЛДИНГ" Ректальные суппозитории для лечения заболеваний предстательной железы, содержащие тетрапептид лизил-глутамил-аспартил-пролин

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005194A (en) * 1975-06-23 1977-01-25 Abbott Laboratories Treatment of prostatic hyperplasia
GB9425582D0 (en) * 1994-12-19 1995-02-15 Iaf Biochem Int Peptides having immunomodulatory activity
EP1065214B1 (de) * 1998-03-25 2005-05-04 Takeda Pharmaceutical Company Limited Neue, physiologisch aktive peptide und ihre verwendung.
ES2297934T3 (es) * 1998-08-03 2008-05-01 Ronald E. Wheeler Formula prostatica.

Also Published As

Publication number Publication date
WO2002066497A3 (en) 2002-10-03
AU2002221216A1 (en) 2002-09-04
DE60105204T2 (de) 2005-04-21
EP1353939B1 (de) 2004-08-25
DE60105204D1 (de) 2004-09-30
WO2002066497A2 (en) 2002-08-29
RU2177802C1 (ru) 2002-01-10
EP1353939A2 (de) 2003-10-22

Similar Documents

Publication Publication Date Title
PL1697370T3 (pl) Azabicykliczne heterocykle jako modulatory receptora kanabinoidowego
NO975334L (no) Anvendelse av flavanolignaner for fremstilling av medikamenter med antiproliferativ aktivitet i uterus, ovarium og bryst
EP1587506A4 (de) Verabreichung von capsaicinoiden
TW200718418A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
IL162294A0 (en) Formulation & dosage form for the controlled delivery of therapeutic agents
MX9200992A (es) Composicion farmaceutica que tiene como ingrediente activo 3-[2-(dimetilamino)etil]-n-metil-1h-indol-5-metanosulfonamida y procedimiento para su preparacion.
DK1623703T3 (da) Hydrocodonformuleringer med kontrolleret frigivelse
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
WO2001068125A3 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
ATE251901T1 (de) Transdermales therapeutisches system für die erzielung hoher plasmaspiegel von rotigotin in der therapie von morbus parkinson
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
MX2007015480A (es) Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
WO2005081742A3 (en) Testosterone oral dosage formulations and associated methods
WO2005014032A3 (en) Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite
ATE274523T1 (de) Tetrapeptid, das prostatafunktionen reguliert sowie seine zusammensetzungen und verwendungen
DE69835461D1 (de) Anti-arrhythmische Zusammensetzungen und Behandlungsverfahren
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
CA2385755A1 (en) Prevention of colorectal cancer
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
RU2007143337A (ru) Фармацевтическая композиция на основе пептида, регулирующего нарушения ангиогенеза, и способ ее применения
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
EP1685835A3 (de) Langzeitapplikation subtherapeutischer Mengen pharmakologischer Wirkstoffe
GEP20002241B (en) Polymorphs and Hydrated Forms of Lesopitron Dichlorohydrate, Methods for Its Preparation and Pharmaceutical Compositions Containing Same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1353939

Country of ref document: EP

EEIH Change in the person of patent owner